Selected research
Market Structure
Global Pain Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pain Patches market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pain Patches include Sanofi, Novartis, GlaxoSmithKline, Viatris, Teva Pharmaceutical Industries, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pain Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pain Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pain Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain Patches market size, projected growth trends, production technologies, key applications, and end-use industries.
Pain Patches Segment by Company
Sanofi
Novartis
GlaxoSmithKline
Viatris
Teva Pharmaceutical Industries
Teikoku Seiyaku
Nichiban
Mentholatum
Johnson & Johnson Services
Hisamitsu Pharmaceutical
Pain Patches Segment by Type
Buprenorphine
Fentanyl
Pain Patches Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online pharmacies
Pain Patches Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pain Patches market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pain Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pain Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Buprenorphine
- Fentanyl
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Online pharmacies
Companies covered
- Sanofi
- Novartis
- GlaxoSmithKline
- Viatris
- Teva Pharmaceutical Industries
- Teikoku Seiyaku
- Nichiban
- Mentholatum
- Johnson & Johnson Services
- Hisamitsu Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pain Patches Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pain Patches Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pain Patches Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pain Patches Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pain Patches Market Dynamics
- 2.1 Pain Patches Industry Trends
- 2.2 Pain Patches Industry Drivers
- 2.3 Pain Patches Industry Opportunities and Challenges
- 2.4 Pain Patches Industry Restraints
3 Pain Patches Market by Manufacturers
- 3.1 Global Pain Patches Revenue by Manufacturers (2021-2026)
- 3.2 Global Pain Patches Sales by Manufacturers (2021-2026)
- 3.3 Global Pain Patches Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pain Patches Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pain Patches Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pain Patches Manufacturers, Product Type & Application
- 3.7 Global Pain Patches Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pain Patches Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pain Patches Players Market Share by Revenue in 2025
- 3.8.3 2025 Pain Patches Tier 1, Tier 2, and Tier 3
4 Pain Patches Market by Type
- 4.1 Pain Patches Type Introduction
- 4.1.1 Buprenorphine
- 4.1.2 Fentanyl
- 4.2 Global Pain Patches Sales by Type
- 4.2.1 Global Pain Patches Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pain Patches Sales by Type (2021-2032)
- 4.2.3 Global Pain Patches Sales Market Share by Type (2021-2032)
- 4.3 Global Pain Patches Revenue by Type
- 4.3.1 Global Pain Patches Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pain Patches Revenue by Type (2021-2032)
- 4.3.3 Global Pain Patches Revenue Market Share by Type (2021-2032)
5 Pain Patches Market by Application
- 5.1 Pain Patches Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Retail Pharmacies
- 5.1.3 Online pharmacies
- 5.2 Global Pain Patches Sales by Application
- 5.2.1 Global Pain Patches Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pain Patches Sales by Application (2021-2032)
- 5.2.3 Global Pain Patches Sales Market Share by Application (2021-2032)
- 5.3 Global Pain Patches Revenue by Application
- 5.3.1 Global Pain Patches Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pain Patches Revenue by Application (2021-2032)
- 5.3.3 Global Pain Patches Revenue Market Share by Application (2021-2032)
6 Global Pain Patches Sales by Region
- 6.1 Global Pain Patches Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pain Patches Sales by Region (2021-2032)
- 6.2.1 Global Pain Patches Sales by Region (2021-2026)
- 6.2.2 Global Pain Patches Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pain Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pain Patches Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pain Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pain Patches Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pain Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pain Patches Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pain Patches Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pain Patches Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pain Patches Revenue by Region
- 7.1 Global Pain Patches Revenue by Region
- 7.1.1 Global Pain Patches Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pain Patches Revenue by Region (2021-2026)
- 7.1.3 Global Pain Patches Revenue by Region (2027-2032)
- 7.1.4 Global Pain Patches Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pain Patches Revenue (2021-2032)
- 7.2.2 North America Pain Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pain Patches Revenue (2021-2032)
- 7.3.2 Europe Pain Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pain Patches Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pain Patches Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pain Patches Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pain Patches Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Pain Patches Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Pain Patches Product Portfolio
- 8.2.5 Novartis Recent Developments
- 8.3 GlaxoSmithKline
- 8.3.1 GlaxoSmithKline Company Information
- 8.3.2 GlaxoSmithKline Business Overview
- 8.3.3 GlaxoSmithKline Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GlaxoSmithKline Pain Patches Product Portfolio
- 8.3.5 GlaxoSmithKline Recent Developments
- 8.4 Viatris
- 8.4.1 Viatris Company Information
- 8.4.2 Viatris Business Overview
- 8.4.3 Viatris Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Viatris Pain Patches Product Portfolio
- 8.4.5 Viatris Recent Developments
- 8.5 Teva Pharmaceutical Industries
- 8.5.1 Teva Pharmaceutical Industries Company Information
- 8.5.2 Teva Pharmaceutical Industries Business Overview
- 8.5.3 Teva Pharmaceutical Industries Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceutical Industries Pain Patches Product Portfolio
- 8.5.5 Teva Pharmaceutical Industries Recent Developments
- 8.6 Teikoku Seiyaku
- 8.6.1 Teikoku Seiyaku Company Information
- 8.6.2 Teikoku Seiyaku Business Overview
- 8.6.3 Teikoku Seiyaku Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Teikoku Seiyaku Pain Patches Product Portfolio
- 8.6.5 Teikoku Seiyaku Recent Developments
- 8.7 Nichiban
- 8.7.1 Nichiban Company Information
- 8.7.2 Nichiban Business Overview
- 8.7.3 Nichiban Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nichiban Pain Patches Product Portfolio
- 8.7.5 Nichiban Recent Developments
- 8.8 Mentholatum
- 8.8.1 Mentholatum Company Information
- 8.8.2 Mentholatum Business Overview
- 8.8.3 Mentholatum Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Mentholatum Pain Patches Product Portfolio
- 8.8.5 Mentholatum Recent Developments
- 8.9 Johnson & Johnson Services
- 8.9.1 Johnson & Johnson Services Company Information
- 8.9.2 Johnson & Johnson Services Business Overview
- 8.9.3 Johnson & Johnson Services Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Johnson & Johnson Services Pain Patches Product Portfolio
- 8.9.5 Johnson & Johnson Services Recent Developments
- 8.10 Hisamitsu Pharmaceutical
- 8.10.1 Hisamitsu Pharmaceutical Company Information
- 8.10.2 Hisamitsu Pharmaceutical Business Overview
- 8.10.3 Hisamitsu Pharmaceutical Pain Patches Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hisamitsu Pharmaceutical Pain Patches Product Portfolio
- 8.10.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pain Patches Value Chain Analysis
- 9.1.1 Pain Patches Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pain Patches Production Mode & Process
- 9.2 Pain Patches Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pain Patches Distributors
- 9.2.3 Pain Patches Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst